Members and Board of Directors

Governance

The CFI was established as an independent, non-governmental organization with a Board of Directors which meets three to four times a year. An annual public meeting is held each year and is widely publicized in several newspapers.

Members

The Board of Directors reports to Members — a higher governing body similar to a company’s shareholders, but representing the Canadian public. Members are responsible for the appointment of seven of the 13 Board Directors. They receive audited financial statements, appoint external auditors, and approve the annual report.

President, R.C. Management

A University of Toronto chemical engineering graduate, Ronald Morrison began his career at Kodak Canada in 1958 and retired in 2001. He has held progressive responsibilities in manufacturing and general management, and was named President and General Manager of Kodak Canada, Inc. in 1984 and Chairman of the Board in 1994. In September 1994, he was appointed General Manager of Kodak Park and Vice President, Eastman Kodak Company. From 1997 to 2001, he was Worldwide Color Paper Flow Manager, Imaging Materials Manufacturing.

He is currently the President of R.C. Management, an organization providing strategy and operational management consulting to a number of North American manufacturing and service organizations. Mr. Morrison was formerly chair of the Canadian Manufacturers & Exporters (CME) National Board of Directors. He returned to a position on the Board after having served as the organization’s acting President and CEO from September 2016 to January 2017. He is a member of the Canadian Industry Program for Energy Conservation’s Executive Board and head of the Canadian delegation to ISO TC/PC 301 Energy Management.

President Emeritus and Vice Chancellor, University of Manitoba

Dr. Emőke J. E. Szathmáry, CM, OM, FRSC, was the tenth President and Vice-Chancellor of the University of Manitoba from 1996 to 2008. Dr. Szathmáry was trained as a physical anthropologist, specializing in the study of human population genetics, and received her Ph.D. in anthropology from the University of Toronto. She held her first administrative post as chairperson of the department of anthropology at McMaster University in Hamilton, Ont., a position she left to become Dean of the Faculty of Social Science at Western University. She returned to McMaster in 1994 to serve as Provost and Vice President (Academic).

Dr. Szathmáry was appointed a member of the Order of Canada in 2003 and in 2004, she was named one of Canada’s top 100 most powerful women by the Women’s Executive Network and the Richard Ivey School of Business. In 2005, she was elected a Fellow of the Royal Society of Canada and in 2009, she received the Order of Manitoba. Dr. Szathmáry was named a Distinguished Lecturer by the American Anthropological Association in 1998 — the highest recognition given by the anthropological discipline for a lifetime of exemplary scholarship.

Retired, Past Vice-President Research, University of Alberta

Lorne A. Babiuk was appointed Vice-President Research at the University of Alberta in 2007, where he served until his retirement in June 2017. He is a leader in Canadian vaccine research specializing in immunology, pathogenesis, virology, molecular virology and vaccinology. Prior to moving to the University of Alberta, he spent 34 years at the University of Saskatchewan where he was responsible for building the successful Vaccine and Infectious Disease Organization (VIDO) research institute. Under Dr. Babiuk’s leadership, VIDO became internationally recognized as a leader in novel vaccine development. As Director of VIDO, Dr. Babiuk completed its $19.4 million expansion in 2005 and obtained funding for InterVac, its $140 million level-three biocontainment facility for work on infectious diseases, which opened in September, 2011.

Dr. Babiuk received his Ph.D. in 1972 from the University of British Columbia and has published over 500 peer-reviewed manuscripts and 100 essays and reviews, primarily in virology and immunology. His most recent focus has been on vaccine formulation and delivery. He is the principal investigator on a Bill & Melinda Gates Grand Challenge in Global Health grant to develop needle-free vaccines for infants and young children. He is a fellow of the Infectious Diseases Society of America, the Royal Society of Canada and the European Academy of Sciences, as well as an Officer of the Order of Canada.

Post Retirement Professor, Former Dean, Faculty of Medicine, Dalhousie University

Dr. Harold Cook is a prominent Canadian scientist with a 28-year career in pediatrics and biochemistry research. He recently completed a term as dean of Dalhousie University’s Faculty of Medicine. In this position, Dr. Cook lead the faculty through an extensive renewal process involving significant executive recruitment and strategic planning designed to meet the changing medical needs of Canada’s Maritime provinces.

Prior to this role, Dr. Cook held a number of positions at Dalhousie, including Associate Dean of Research and Planning for the faculty, and Interim Dean. Dr. Cook served on the board of the Capital District Health Authority and the IWK Health Centre, and was chair of the Association of Faculties of Medicine of Canada in 2008-09. He has served as Director of the Atlantic Research Centre at Dalhousie University, as leader of the clinical genetics program, and as an affiliated scientist at the IWK Health Centre. He was a visiting professor at Harvard University and at the University of British Columbia.

At Dalhousie, he continues to be a professor of pediatrics and an associate professor of biochemistry and molecular biology.

He is one of the leading authorities on fatty acids and lipids with 130 peer-reviewed papers and book chapters to his credit. Dr. Cook is a graduate of NSAC, Macdonald College at McGill University and Dalhousie University. His post-doctoral fellowship was completed at the University of Michigan.

General Partner and co-founder, AmorChem

Elizabeth Douville is General Partner and co-founder of AmorChem, a Québec-based seed venture fund dedicated to financing and commercializing university-based life sciences technologies. Launched in 2011 with a capital of $41.25 million, the AmorChem fund model uniquely combines access to financial resources with a virtual incubator structure that enables the rapid development and commercialization of life science technologies. Today, the fund has successfully built a portfolio of 24 technologies, has leveraged its initial capital to close to $76 million with non-dilutive sources, has transacted two pharma exits and has spun out a first biotech company.

Dr. Douville was General Partner of GeneChem, a leading North American life sciences venture capital fund manager. She joined the company in 1997, moving rapidly from manager to partner with the different funds under management. She was an active board member for many Canadian and American portfolio companies where she contributed to their development and exit strategies.

Today, she is an active board member of BioQuebec (the biotech industry association for the province), BioCanRx (a Network of Centres of Excellence for bio-therapeutics in oncology) and Genome Canada (a not-for-profit organisation for developing genomic-based technologies to create economic and social benefits for Canadians). Dr. Douville trained as a biochemist, obtaining her PhD from the University of Ottawa and was a post-doctoral fellow with the Imperial Cancer Research Fund in London, UK. In 2008, Elizabeth obtained a business certificate degree from the Centre interuniversitaire de recherche sur la première modernité (CIREM) in collaboration with Hautes Études Commerciales (HEC)/Université de Montréal.

Former Senior Vice-President, B.C. and Yukon Division, Personal and Commercial Banking, Bank of Montreal

Joanne Gassman joined the Bank of Montreal (BMO) in 1974 and worked in several markets both in British Columbia and Toronto, where she assumed increasingly more senior positions in both the corporate audit and personal and commercial banking departments. Her first executive appointment with BMO was in 2005 as Vice-President, Vancouver Island and in 2008 she was promoted to Vice-President Retail Banking for Greater Vancouver. In 2011, she was appointed to Senior Vice-President, B.C. and Yukon Division, Personal and Commercial Banking, a position she retired from in 2014.

Upon retirement, Ms. Gassman took on a new, one-year, national consulting role with BMO Financial Group, as Senior Vice-President, Women’s Market. In this capacity, Joanne promoted BMO’s focus on the needs of women entrepreneurs by improving the business and financial information available for women and by facilitating self-sufficiency and success for women business owners and managers. Ms. Gassman is a member of the Board of Advisors for GroYourBiz, an initiative developed for women entrepreneurs who want to take their business to the next level. She is also a member of both the Women’s Business Economic Advisory Board and the International Women’s Forum.

Ms. Gassman is currently chair of the Bill Reid Gallery of Northwest Coast Art and of the Vancouver Council for CARE Canada. She is a Director for Streetohome and for the Bowen Island Community Foundation. She is a past Governor of BC Children’s Hospital Foundation, and a supporting member of Kidsafe Project Society. Ms. Gassman is on the University of Northern British Columbia Advisory Committee and was previously on the University of Victoria Board of Advisors. She is a Fellow of the Institute of Canadian Bankers and has an MBA from Dalhousie University.

In 2015, she was recognized by the Association of Women in Finance and received the Lifetime Achievement award. She was also recognized by The International Alliance for Women (TIAW) and was a recipient of the 2015 TIAW World of Difference Award.

Vice President Research, Research Institute of St. Joseph’s Healthcare, Distinguished University Professor, Pathology and Molecular Medicine, McMaster University

Dr. Jack Gauldie was appointed Vice President of Research and Director of the Research Institute of St. Joseph's Healthcare Hamilton in March 2015. He is Distinguished University Professor and Professor, Department of Pathology and Molecular Medicine at McMaster University, where he is a member of the McMaster Immunology Research Centre. He was chair of the Department of Pathology and Molecular Medicine, encompassing both clinical laboratory medicine and basic biomedical research, from 1989 to 2004.

Dr. Gauldie completed his B.Sc. at McMaster University in Hamilton, Ont. and Ph.D. at University College London in the U.K. before returning to the new medical school at McMaster in 1970. He has conducted research in immunology, inflammation, infectious diseases and vaccine development for the past 40 years. Dr. Gauldie is recognized internationally for his work in defining the molecular regulation of acute and chronic inflammatory responses and is a world expert in the areas of cytokine biology, pulmonary fibrosis and mucosal immunity. He has published over 370 scientific articles and a number of book chapters.

Dr. Gauldie is chair of the advisory board of Ontario Research Fund (ORF), a member of the scientific advisory board of Health Canada and a member of the board of the Ontario Genomics Institute. He is a Fellow of the Royal Society of Canada and the Royal College of Physicians (Edinburgh). He was a member of the advisory board of the Institute of Infection and Immunity of the Canadian Institutes of Health Research (CIHR) and was co-chair of the Medical Review Panel of the Gairdner Foundation.

He has received awards from the Canadian Society for Immunology, the Canadian Medical Association and the Canadian Society of Clinical Chemists, and is a frequent evaluator for granting agencies including CIHR, the National Institutes of Health (U.S.) and the Medical Research Council (U.K.).

Retired, Past Vice President, Corporate Affairs, Alberta Innovates (2012)

Linda Humphreys is a Certified Professional Accountant (CPA, CMA) who has held senior management positions with Alberta Innovates Health Solutions, and its predecessor — the Alberta Heritage Foundation for Medical Research — for 20 years. She has been Chief Financial Officer, and Director and Vice President responsible for Technology Commercialization. Most recently, Ms. Humphreys was the Vice President of Corporate Affairs until she retired in 2012. In June 2018, she was appointed as Vice-Chair of Alberta’s Rural Health Professions Action Plan.  She is a mentor with Immigrant Services Calgary and also participated on several other boards including Inno-Centre Alberta, the Alberta Science and Technology Awards Foundation, Alberta Aviation Council and the Canadian Breast Cancer Foundation. She was a volunteer instructor for the Board Development Program in Alberta, and a mentor with the career centre at the University of Alberta. She has been involved in the establishment and development of private sector companies developing technology in the oil sands.

President and CEO New Brunswick Community College 

Marilyn Luscombe is New Brunswick Community College’s (NBCC) inaugural president and chief executive officer. She was first appointed in 2010 and re-appointed for a second term in 2014. During this time, NBCC has moved from a six-college structure to a new One College - One Team structure.  In addition to maintaining a strong reputation for high quality and relevant programs, NBCC has also initiated a number of innovations under Ms. Luscombe’s leadership. These include the award-winning Robertson Institute for Community Leadership, a new entrepreneurial mentorship program, and an office of applied research and innovation.

A native of Newfoundland and Labrador, Ms. Luscombe has extensive experience in publicly-funded community colleges, having served at the College of the North Atlantic for fifteen years and as President and CEO at Selkirk College in the West Kootenay Region of B.C. for over ten years, from 2000 to 2010.

Ms. Luscombe has been heavily involved in advancing Canada’s colleges as former Chair of the Atlantic Provinces Community Colleges Consortium, former Chair of the Canadian College Presidents’ Network Executive and three years as Chair of the Association of Canadian Community Colleges (now Colleges and Institutes Canada). She currently serves on the President’s Advisory Committee on Science and Technology for Colleges and Institutes Canada as well as on the boards of the Atlantic Provinces Economic Council, the Atlantic Ballet Theatre of Canada and the New Brunswick Social Policy Research Network.

Ms. Luscombe was named one of Atlantic Canada’s Top 50 CEOs by Atlantic Business Magazine in 2015.

Chief Development Officer, Therillia Development Company Inc.

Dr. Louise Proulx holds a Ph.D. in physiology from Université Laval and pursued postdoctoral studies at the Karolinska Institute in Stockholm, Sweden. She has close to 30 years of experience in research and development management. Over the years she has held scientific positions of increasing responsibilities, notably as Vice President, Scientific Affairs at Hoechst Marion Roussel Canada, Vice President, Therapeutic Product Development at BioChem Pharma Inc., Vice President, Business Development of Genome Quebec and Vice Principal Research at McGill University. Following her post at McGill, she returned to the pharmaceutical industry where she was Vice President, Product Development at ViroChem Pharma Inc. and then Vice President and Site Head at Vertex Pharmaceuticals (Canada) Inc. after the acquisition of ViroChem Pharma by Vertex Pharmaceuticals. She is now Chief Development Officer at Therillia Development Company Inc.

Dr. Proulx has been a member of several boards of directors and is currently a member of the board of directors of the Research Institute of the McGill University Health Centre, Gestion Univalor, Verlyx Pharma and CQDM (formerly known as Quebec Consortium for Drug Discovery). Dr. Proulx is certified ICD.D by the Institute of Corporate Directors.

Past Chair of the Board for Public Health Ontario and former Senior Partner and Counsel with McMillan (Lang Michener)

Pierre Richard, Q.C., is a fluently bilingual lawyer. He served as Senior Partner and Counsel with Lang Michener's Ottawa office, with a focus on business law, acquisitions, advocacy and regulatory matters. Mr. Richard has been a member of Public Health Ontario’s Board since 2009, and Chair from 2014 to 2017. An active member of the Ottawa business community, he brings more than three decades of experience in government, health, post-secondary education and electricity generation and distribution. He is a skilled leader and communicator, who is well-recognized for his abilities in strategic planning, alliance-building and relationship management.

Mr. Richard has served on a number of boards including the Ottawa General Hospital, Hydro Ottawa Holding Inc., La Cité collégiale, the Association of Colleges of Applied Arts and Technology of Ontario (now Colleges Ontario), the National Capital Commission, the Ottawa Congress Centre, and the College Compensation and Appointments Council (Ontario). He was also a member of Departmental Audit Committees at Transport Canada, Infrastructure Canada and the RCMP. He earned his Master of Laws at Harvard University, and is a member of the Institute of Corporate Directors.

President and Vice Chancellor, University of Regina

As President and Vice Chancellor of the University of Regina since September 1, 2008, Dr. Vianne Timmons has taken a leading role in determining the strategic direction of the university, where she also maintains a wide-ranging research program, with particular emphasis on family literacy and inclusive education. She is active in the academic community regionally, nationally and internationally, currently serving as President of the International Association for the Scientific Study of Intellectual Disabilities, chair of the Canadian Bureau for International Education, and Vice President – Canada Region of the Inter-American Organization for Higher Education.

Dr. Timmons was named one of Canada’s top 100 most powerful women from 2008 through 2011, and in 2009, was also named one of the 10 most influential women in Saskatchewan. In 2009, she received the Canada Post Community Literacy Award for education, and in 2010 she received the Canadian Association for Community Living’s National Inclusive Education Award. Dr. Timmons received her Bachelor’s of Arts in 1979 from Mount Allison University and her Bachelor’s of Education in 1980 from Acadia University. In 1983, she completed her Master of Education at Gonzaga University in Spokane, Washington, and she earned her Ph.D. in education psychology in 1993 from the University of Calgary. Dr. Timmons is the winner of a 2019 Indspire Award representing the highest honour that the Indigenous community bestows on its own people. 

Director of Centre de recherches mathématiques and Aisenstadt Professor of Physics, Université de Montréal

Dr. Luc Vinet has been Provost of McGill University and Rector of the Université de Montréal (U de M). He is well-known for his work in gauge theories and at the interface of integrable systems and algebraic combinatorics. His current research interests bear on mathematical physics, representation theory, orthogonal polynomials and quantum information. He often organizes various international meetings and is a sought-after speaker. As Director of the Centre de recherches mathématiques (CRM) at U de M, Dr. Vinet has spearheaded various initiatives — such as Mitacs, which is an organization to facilitate partnerships between industry and academia — that have shaped Canadian mathematical sciences. He is regularly part of expert panels and is a member of various boards and advisory committees. The Quebec Armand-Frappier prize and the Canadian Association of Physicists’ (CAP) CAP-CRM medal in theoretical and mathematical physics are among the recognitions he has received. In 2018, Dr. Vinet was elected Fellow of the Royal Society of Canada.

Board of Directors

The Board of Directors is made up of 13 individuals — six of whom are appointed by the Government of Canada — from a variety of backgrounds, each with a unique perspective and understanding of the research world. The Directors are appointed for a three-year renewable term and bring with them expertise in the private, institutional, academic, research, and government sectors. One Director on the Board is a representative from one of the federal granting agencies.

The Board of Directors makes final decisions on projects to be funded and sets strategic objectives in the context of the funding and contribution agreements. It approves annual plans and objectives, and reviews the outcomes of these objectives each year. It regularly reviews issues from a risk-assessment perspective — determining what risks are acceptable and ensuring that appropriate mitigation steps are in place. As well, the Board sets the CFI’s overall compensation policy, and specifically sets compensation for management.

Directors designated with a * are appointed Governor-in-Council (and therefore a public office holder ) by the Government of Canada

Canada Research Chair in Molecular Environmental Science, University of Saskatchewan

Dr. Ingrid J. Pickering is a professor and Canada Research Chair in Molecular Environmental Science at the University of Saskatchewan. She received her undergraduate degree from the University of Cambridge and her Ph.D. from Imperial College, University of London, based at the Royal Institution of Great Britain. She came to Canada from Stanford University. Her research uses and develops synchrotron X-ray techniques to study metals and other elements in biological systems of relevance to the environment and human health. She is closely associated with the Canadian Light Source — Canada’s first synchrotron — where she co-leads the development of three new experimental stations.

Dr. Pickering was ranked among the top three researchers in Canada in geology and earth sciences by h-index (Higher Education Strategy Associates (HESA) survey) in 2012. She receives funding from several sources including the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR) and has served on a number of international advisory panels for synchrotron facilities. She currently leads the CIHR training program in Health Research Using Synchrotron Techniques at the University of Saskatchewan. In 2018, Dr. Pickering was elected Fellow of the Royal Society of Canada.
 

Former Federal Deputy Minister and National Security Advisor

Margaret Bloodworth was born and raised in Winnipeg, Manitoba. She received a Bachelor’s of Arts from the University of Winnipeg, a Certificate in Education from the University of Manitoba and a Bachelor’s of Law from the University of Ottawa.

Ms. Bloodworth was a federal public servant for more than 30 years, and most recently Associate Secretary to the Cabinet and National Security Advisor from 2006 to 2008. Prior to this she was the first Deputy Minister of Public Safety (2003–2006), Deputy Minister of National Defence (2002–2003) and Deputy Minister of Transport (1997–2002).

She has been appointed to the Order of Canada, and is the recipient of the Public Service of Canada Outstanding Achievement Award, the Vanier Medal of the Institute of Public Administration of Canada, an honorary degree from the University of Winnipeg and an honorary diploma from the Canadian Coast Guard College. She is a charter member of the Common Law Honour Society of the University of Ottawa.

Currently, Ms. Bloodworth chairs the boards of the Council of Canadian Academies and Cornerstone Housing for Women and is a member of the boards of the Community Foundation of Ottawa and the World University Service of Canada. She is also a Senior Fellow Graduate at the School of Public and International Affairs at the University of Ottawa and a member of the advisory board to the Munk School Masters of Global Affairs at the University of Toronto.

Corporate Director

Ms. Micheline Bouchard is a professional engineer as well as a corporate director, serving on the boards of TELUS Corporation, International Women’s Forum and PSP Investments, the public sector pension investment board. She has extensive experience as a director with public and private companies and volunteer boards. Her past board memberships include Harry Winston Diamond Corporation (now known as Dominion Diamond Corporation), Banque Nationale de Paris, Ford Motor Canada, London Insurance Group, and Home Capital/Home Trust.

Ms. Bouchard previously served as President and Chief Executive Officer of ART Advanced Research Technologies, a biomedical company, from 2002 to 2006. Prior to that, she was Global Corporate Vice President of Motorola Inc. in the U.S. after serving as President and Chief Executive Officer of Motorola Canada Inc. She holds a bachelor's degree in applied sciences (engineering physics) and a master’s degree in applied sciences (electrical engineering) from École Polytechnique de Montréal. She has been awarded five honorary doctorates from major Canadian universities. Ms. Bouchard is a member of the Order of Canada, a member of the National Order of Quebec, a certified member of the Institute of Corporate Directors, a recipient of the Gold Medal Award from Engineers Canada and of the Grand Prix d’excellence from the Ordre des ingénieurs du Québec.

CEO, Strategic Technology Leadership Corporation

A senior executive and CEO, Catherine Aczel Boivie has led the advancement of the strategic value of information technology as a business enabler at Vancity (Canada's largest Credit Union), Pacific Blue Cross and CAA British Columbia. She is the CEO of Strategic Technology Leadership Corporation (STLC) that specializes in advisory services on IT governance and the strategic use of technology. She recently completed six years as Executive in Residence at the Beedie School of Business, Simon Fraser University in Vancouver.

Dr. Boivie is a certified member of the Institute of Corporate Directors and is a Director/Chair on the boards of the Commissioner for Complaints for Telecom-television Services (CCTS), the Arts Club Theatre Company and the MedicAlert Foundation Canada. Catherine, as the Co-President on the Vancouver Women in Technology (VanWIT) board, is a strong advocate for encouraging women to enter, stay and thrive in technology field.

Catherine has a BMath degree from University of Waterloo, MEd and PhD from University of Toronto and has been publicly recognized for her contributions, including being named twice as one of WXN Canada's top 100 most powerful women in the "Trailblazers and Trendsetters" category, received the University of Waterloo Mathematics Alumni Achievement Medal as well as the Queen Elizabeth Diamond Jubilee medal for being a "catalyst for technology transformation".

She believes that one has to “put back into society what one takes out”. Hence she was instrumental in establishing various funds to assist others: YWCA of Vancouver, to provide high quality child care to support single mothers wishing to return to further their education; the Boivie Family Fund (BFF) at the Beedie School of Business at Simon Fraser University to support women in technology; Arts Club Theatre Company to advance women in the theatre and University of Waterloo to provide financial assistance for graduate students in mathematics.

Founder and CEO, Curatio

Ms. Lynda Brown-Ganzert is the founder and CEO of Curatio, a patient matchmaking platform in a private mobile social network that helps patients find one another and the support they need. Widely regarded as a digital media expert who has played an active role in growing the sector across Canada, Ms. Brown-Ganzert served as Vice President at Nordicity, a leading consulting firm specializing in policy, strategy, and economic analysis in the media, creative and information and communications technology sectors from 2011 to 2013. She was instrumental in helping establish in 2007 the Master of Digital Media program as the first jointly credentialed academic program offered at the Centre for Digital Media, which is accredited by its four partner institutions, The University of British Columbia, Simon Fraser University, Emily Carr Institute of Art + Design and the British Columbia Institute of Technology.

Ms. Brown-Ganzert has won numerous awards as an entrepreneur, including Business in Vancouver’s Top Forty Under 40, Novartis Health 2.0 Global Challenge and Metabridge 2015 for the top 15 Canadian emerging tech startups. She has served on numerous boards, including the Canadian Interactive Alliance, Information Technology Association of Canada and Pacific Cinematheque, and she was most recently recognized as chair emerita at Simon Fraser University, where she had previously graduated with a Master’s of Education and a Bachelor’s of Arts (Communications) degrees.

CEO, KeliRo Company

Dr. John Kelly is CEO of KeliRo Company, a company that provides consultancy services to the life sciences sector. He is also President of DNAstack, a genomics bioinformatics company in Toronto and he is the Senior Innovation Advisor for Bioenterprise Corporation, focused on innovation in agri-technologies. He has a wealth of experience in the private and public sector and has held various executive and Board of Director positions with start-ups and multinational companies, including the Ontario Fruit and Vegetable Growers’ Association, Life Sciences Ontario, Ontario South Coast Wineries and Growers Association, Ontario Genomics, Ontario Hazelnut Association, Ontario Lavender Association, MaRS Landing, Land O’Lakes, Ralston Purina, Rhone-Poulenc Canada Inc. and Aventis CropSciences Inc., as well as the Ontario Ministry of Agriculture, Food and Rural Affairs. Dr. Kelly is also Adjunct Professor in the Department of Plant Agriculture and formerly in the Department of Animal Biosciences at the University of Guelph.

Dr. Kelly has an extensive background working with entrepreneurs and innovation in human health and life sciences, agriculture, food and bio-economy sectors in domestic and international markets. An extensive publisher, he has authored hundreds of research and extension publications throughout his career, attracted several million in investment and been a serial entrepreneur and investor. Throughout his career, he has been focused on innovation development and implementation, actively advancing products and technologies in agriculture, food, biotechnology, pharma and the bioeconomy sectors.

Dr. Kelly has a B.Sc. (Agr.) and Ph.D. from the University of Guelph and a Master of Science from the University of Alberta.

President and CEO, Tidal Pool Ventures Inc.

Dr. Ronald Layden is President and CEO of Tidal Pool Ventures Inc., a consulting company, specializing in research studies, valuations and northern research. Since 2001, he is also the Senior Advisor and VP Life Sciences for Venture Valuation AG (Zurich, CH), where he is involved in company and product valuations and assessments. His previous roles include CEO of a biotechnology company; venture capitalist and co-founder of several businesses; and a senior manager in the pharmaceutical industry, with assignments at Roche, Bayer and Eli Lilly. From 2005 to 2010, Dr. Layden was the Executive Director of Industry Liaison and Innovation at Dalhousie University, where he created a new department for commercializing academic research, carrying out applied research studies with the private sector and developing spinout companies.

Dr. Layden has research and laboratory experience in oil field chemistry, immunology, molecular biology, environmental studies and genetics. Most recently, he directed applied climate change and northern research studies at the Aurora Research Institute in Yellowknife. Research projects included studies on the hydrology of the Snare Hydro System, analysis of groundwater and drinking water in the community of Whati, landscape surveys for methane and other greenhouse gases in the Mackenzie-Beaufort Delta and the feasibility of using novel solid waste gasification systems in northern communities.

Dr. Layden was a postdoctoral research fellow at the Fred Hutchinson Cancer Research Center in Seattle, Washington, where he studied trans-splicing in African trypanosomes and the implications for host-immune responses. Dr. Layden also studied zebrafish brain development at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland. Dr. Layden earned his Ph.D. at Western University (the University of Western Ontario) and his B.Sc. from Dalhousie University, both in biochemistry.

Professor, Animal Physiology, Dalhousie University

Dr. Leslie A. MacLaren is a professor of animal physiology at Dalhousie University and brings extensive experience in leadership in academia. In June 2015 she completed a two-year term as the Academic Vice President and Provost at St. Francis Xavier University (StFX). Prior to her appointment at StFX, Dr. MacLaren was the Associate Dean Academic in the Faculty of Agriculture and a professor in the Department of Plant & Animal Sciences at Dalhousie University. She served five years as Co-President of the Nova Scotia Agricultural College (NSAC) from 2007 to 2012, as well as seven years as Vice President Academic, from 2005 to 2012. She served as Dean of Research, and has been a faculty member at NSAC since 1994. Dr. MacLaren is a specialist in reproductive and molecular physiology. She holds a Ph.D. in physiology from the University of California, Davis, a Master’s of Science in animal breeding and genetics from the University of Alberta, and a Bachelor’s of Science in agriculture from the University of Guelph.

Her professional appointments and service are extensive. She recently completed terms as an executive member, Senior Women Academic Administrators of Canada and as a member of the NSERC Committee on Research Partnerships. She has served as NSAC’s representative on the Council of Nova Scotia University Presidents, Association of Atlantic Universities, Association of Universities and Colleges of Canada (now Universities Canada), Dalhousie University Senate, and the Association of Community Colleges of Canada (now Colleges and Institutes Canada). Dr. MacLaren was also the board chair of Performance Genomics Inc., and has been a member of such organizations as Canadian Faculties of Agriculture & Veterinary Medicine, Science Atlantic (formerly APICS - Atlantic Provinces Inter-University Committee on the Sciences) and the review committee of Nova Scotia’s technology development program, and was the NSAC liaison for the Maritime Provinces Higher Education Commission.

Professor of Electrical and Computer Engineering, Memorial University of Newfoundland

Dr. Cecilia Moloney has been a faculty member with Memorial University of Newfoundland since 1990. From 2004 to 2009, she held the Natural Sciences and Engineering Research Council of Canada (NSERC)/Petro-Canada Chair for Women in Science and Engineering, Atlantic Region. It is one of five regional NSERC Chairs for Women in Science and Engineering. In 2010, she started The MetaKettle Project, as a legacy project from the Chair, with the goal of increasing the diversity of students studying science and engineering, while enhancing the sustainability of the careers of graduates throughout their lives.

Dr. Moloney contributes to research in non-linear image processing methods and radar signal processing, as well as to collaborative multidisciplinary research on diversity and pedagogy in engineering. She has made numerous service contributions to the advancement of research, including serving on NSERC selection committees and as an interim Associate Dean of Engineering (Research) at Memorial University. She is a member of the Advisory Committee on Civic Engagement for the Leslie Harris Centre of Regional Policy and Development, a Fellow of Women in Science and Engineering Newfoundland and Labrador (WISE NL), and a former Chair of the Institute of Electrical and Electronics Engineers (IEEE) Newfoundland and Labrador Section.

Professor and Canada Research Chair in Antimicrobial Resistance, Université Laval

Dr. Marc Ouellette is a professor in the Department of Microbiology-Infectious Diseases and Immunology at the Université Laval School of Medicine. He holds a Canada Research Chair in antimicrobial resistance and is an investigator at the Infectious Diseases and Immunity Axis of the Research Centre of the CHU de Québec-Université Laval. His work focuses on antimicrobial resistance where he has made seminal discoveries on resistance mechanisms in protozoan parasites and in bacteria.

Dr. Ouellette obtained his Bachelor of Science (Honours) in Biochemistry at the University of Ottawa and received his PhD at Université Laval on antibiotic resistance in bacteria. He was the Scientific Director of the CIHR Institute of Infection and Immunity from 2010 to 2018. He has received numerous awards for his work including a New Investigator Award in Molecular Parasitology and a Scholar Award in Molecular Parasitology from the Burroughs Wellcome Fund, as well as a Scientist Award from the Medical Research Council of Canada. Dr. Ouellette is a Fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences. He has served on numerous panels or boards of national and international granting agencies and research organizations and is a strong supporter of scientific exchanges with developing countries.

Ian Seymour

Former Vice-President, Finance and Corporate Secretary, International Institute for Sustainable Development

Ian Seymour earned his Chartered Accountant designation in 1975 and was admitted to partnership at Price Waterhouse in 1985. During his time there, he led practice units in Ottawa and Winnipeg where he served the needs of a wide range of clients including public and private companies, government and non-government organizations. He joined the International Institute for Sustainable Development (IISD) as Operations manager in 1992, retiring as its Vice-President, Finance and Corporate Secretary in 2013.

Mr. Seymour served his profession as President and Chair of the Institute of Chartered Accountants of Manitoba from 2009 to 2010 and earlier as a member of its national board of examiners as well as on numerous other committees. He has served the community as President of the Rotary Club of Winnipeg, Treasurer of the Heart and Stroke Foundation of Manitoba, Finance Chair of the Children’s Hospital Foundation of Manitoba Teddy Bears’ Picnic, President of the Volunteer Centre of Winnipeg, President of the University of Winnipeg Alumni Association and as an officer and Director of the Manitoba Chambers of Commerce. Mr. Seymour was elected a Fellow of the Institute of Chartered Accountants of Manitoba in 2010 and a Fellow of the Chartered Professional Accountants of Manitoba in 2015. In 2016 he received the Chartered Professional Accountants Manitoba Meritorious Service Award for his contribution to uniting the accounting profession in Manitoba.

Mr. Seymour is currently serving as an officer and director of the Manitoba Seniors Golf Association Inc.

Retired, Past President and Vice-Chancellor, York University

Dr. Mamdouh Shoukri was appointed the seventh President and Vice-Chancellor of York University on July 1, 2007. He completed his decade-long tenure as President on June 30, 2017. A champion of innovation, Dr. Shoukri guided York’s transformation into a comprehensive and research-intensive university. As President, he established the Lassonde School of Engineering and initiated several major capital development projects.

Dr. Shoukri began his career in academia at McMaster University, where his scholarly work focused on the area of thermofluid sciences. He held several administrative leadership positions, including Department Chair, Dean of Engineering and Vice-President Research. In 2004, he was responsible for creating and implementing the vision for the McMaster Innovation Park, which has become a major innovation hub and catalyst for the region’s economic recovery. Prior to joining McMaster, Dr. Shoukri worked in research and development in the Canadian nuclear industry for seven years.

Dr. Shoukri served on the Board of Directors of a number of organizations including Cancer Care Ontario, Universities Canada, Loran Scholars Foundation, York Central Hospital, was a founding Board Member of the Ontario Centres of Excellence and was a member of the Ontario Research and Innovation Council.

Dr. Shoukri was named a Member of the Order of Canada and the Order of Ontario in 2013, and was awarded the Queen Elizabeth II Diamond Jubilee Medal. He is a Senior Fellow of Massey College and a Fellow of the Canadian Academy of Engineering and the Canadian Society for Mechanical Engineering. Dr. Shoukri’s scholarly interests are in thermofluid science.

Committees

As per its bylaws, the Board established three standing committees, specified their duties and delegated such powers and duties as it deemed advisable. All committee members are appointed by the Board from among the Directors and they hold office for terms of one year.

The Board of Directors oversees management’s responsibilities for financial reporting through its Audit and Finance Committee. This committee reviews the financial statements and recommends them to the Board of Directors for approval which are then received by the Members. The Board of Directors approves the CFI's financial controls and audits and is accountable to the Members. Other key responsibilities of this committee include reviewing the budgets, internal control procedures, and advising the Directors on auditing matters and financial reporting issues.

Current members:

  • Ian Seymour, Chair
  • Lynda Brown-Ganzert
  • Leslie MacLaren
  • Ingrid Pickering

The Investment Committee oversees all matters related to the investment management of amounts received from the federal government in accordance with the Funding and Contribution Agreements. This committee establishes an investment strategy and an investment policy which are reviewed annually.

Current members:

  • Micheline Bouchard, Chair
  • Ingrid Pickering
  • Ian Seymour

The Governance and Nominating Committee ensures that the proper framework is in place for the CFI to operate in the most efficient and accountable manner. Among other things, this committee is responsible for amendments to by-laws, human resources policies, succession planning, the annual performance evaluation of the President, and the code of conduct that governs the Board of Directors, CFI employees, and reviewers.

The committee regularly reviews Board effectiveness and establishes procedures to follow when filling vacancies on the Board and for Members.

Directors and Members are nominated, and then appointed for a three-year term for Directors, and for a five-year term for Members. The Board has chosen to use the guidelines established by the Government of Canada entitled, “Remuneration Guidelines for Part-Time Governor in Council Appointees in Crown Corporations.”  Directors who opt to receive remuneration from the CFI are entitled to an annual retainer of $5,000, while committee chairs receive $7,500 and the Board Chair $10,000. They are also entitled to receive a per-meeting fee of $750 for attending Board or committee meetings, and a $500 fee for attending a committee meeting associated with a Board meeting. Members are not entitled to any remuneration. However, they may be reimbursed for any reasonable out-of-pocket expenses they incur while performing their duties or attending CFI Member meetings.

Current members:

  • Margaret Bloodworth, Chair
  • Cecilia Moloney
  • Ingrid Pickering
  • Louise Proulx, Chair
  • Harold Cook
  • Jack Gauldie
  • Vianne Timmons